SUBLIVAC FIX Mite Mixture Dose Tolerability Study

NCT02345278 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

HAL Allergy